[Skip to Navigation]
Sign In

Featured Clinical Reviews

July 7, 2004

Aggressive Lipid-Lowering Therapy and Regression of Coronary Atheroma

JAMA. 2004;292(1):38. doi:10.1001/jama.292.1.38-a

To the Editor: In their randomized controlled trial, Dr Nissen and colleagues1 reported that a daily dose of 80 mg of atorvastatin was associated with a greater reduction in the volume of coronary atheromas than was a daily dose of 40 mg of pravastatin. The authors concluded that their results supported aggressive cholesterol-lowering therapy.

Add or change institution